FY ended Dec 31, 2025 · figures in PHP except per-share rows
| Item | Current | Previous |
|---|---|---|
| Current assets | 640,445,507 | 667,214,322 |
| Total assets | 1,047,129,706 | 1,143,574,571 |
| Current liabilities | 424,002,067 | 545,622,679 |
| Total liabilities | 449,923,773 | 556,769,515 |
| Retained earnings/(deficit) | 301,891,010 | 295,912,879 |
| Stockholders' equity | 597,205,933 | 586,805,056 |
| Stockholders' equity (parent) | — | — |
| Book value per share | ₱2.16 | ₱2.14 |
| Item | Current | Previous |
|---|---|---|
| Gross revenue | 199,389,035(-16.2%) | 237,840,139 |
| Gross expense | 184,647,372 | 213,520,995 |
| Income/(loss) before tax | 14,741,663 | 24,319,144 |
| Net income/(loss) after tax | 10,316,857(-28.7%) | 14,462,421 |
| Net income/(loss), parent | — | — |
| EPS (basic) | ₱0.04 | ₱0.05 |
| EPS (diluted) | ₱0.04 | ₱0.05 |
Makati Finance Corporation (MFIN) was incorporated on February 17, 1966 as Makati Investment & Finance Corporation. MFIN's commercial operations started with engaging in stock dealership functions, credit line extensions, and acceptance of private placements. In mid-2000s, MFIN shifted its focus on the growth and expansion of its operations and lending activities.
The Company has three main operating units that represent each main business line. These are Rx Cashline Group, which offers loans specifically tailored for medical professionals; Motor Vehicles Financing Group, which grants loans to motorcycle and car buyers; and Business Loans Group, which provides loans to business owners who wish to expand its business or for the purpose of starting capital. Beginning 2024, the MFIN has discontinued its car loan financing program due to competitive interest rates offered by local banks.
MFIN has also expanded its product lines to include new financial products, such as corporate salary loans, personal loans, micro business loans, pension loans, car loans, and leisure bikes financing. These loans are only offered domestically.
TTM total
₱0.01
Makati Finance Corporation trades on the Philippine Stock Exchange under the ticker symbol MFIN.
MFIN is listed in the SME Board sector of the Philippine Stock Exchange, where it ranks #6 of 9 by market capitalization. Across the whole exchange it is #248 of 282, at ₱527.5M.
Yes. MFIN has paid 1 cash dividend in the last twelve months, totalling ₱0.01 per share. Cash dividends have a 10% final withholding tax deducted before they reach your account.
In its latest annual filing (fiscal year ended Dec 31, 2025), MFIN's revenue fell 16.2% and net income fell 28.7% versus the prior fiscal year. That's one year-over-year comparison, not a multi-year trend, so check the Balance sheet & income statement panel above for the full figures before drawing a conclusion.
PSEye doesn't rate stocks as good or bad buys. What this page can tell you is factual: where MFIN ranks by market cap (#248 of 282 on the exchange), its price history, valuation ratios, dividend record and recent company disclosures, all shown above. Whether that adds up to a good stock depends on your own criteria, and is worth researching beyond any single page, including this one.
PSEye is a data tracker, not a financial advisor, so it can't tell you whether to invest in MFIN or any other stock. The price, valuation, dividend and disclosure data on this page is meant to help you do your own research. Consider your own goals, risk tolerance and time horizon, and consult a licensed financial advisor before making an investment decision. If you're weighing a fixed, regular investment instead of a single lump sum, PSEye's DCA calculator shows how that strategy would have performed historically.
To buy MFIN shares, open an account with a PSE-accredited stockbroker (most Philippine banks and several standalone brokers offer online trading accounts), fund it, and place a buy order using the ticker symbol MFIN. A completed trade typically settles two trading days later (T+2). PSEye doesn't process trades or recommend a specific broker.
Delayed/EOD data, not real-time. Figures are statistics on past closing prices, not a forecast.